Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by. If your question has been answered and you'd like to remove yourself from the queue, simply press star 11 again. As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Sue Dooley, Investor Relations. Please go ahead, ma'am. Thank you. And hello, everyone. We appreciate you joining us today. Leading today's call are our Chief Executive Officer, Caitlin Zulla, and Tony Martin, our Chief Financial Officer. Before we begin, I want to note that today's discussion will include forward-looking statements, including statements regarding our 2026 guidance, expected operating performance, growth initiatives, reimbursement assumptions, capital expenditures and other future events. These statements reflect our current expectations and assumptions, which are subject to risks and uncertainties that could cause actual results to differ materially. Please refer to the forward-looking statements and risk factors described in today's earnings release and our most recent SEC filings for additional information. We undertake no obligation to update these statements. We will also discuss certain non-GAAP financial measures, definitions, and reconciliations to the most directly comparable GAAP measures are included in today's earnings release. With that, I will now turn the call over to Caitlin. Caitlin, please go ahead. Thanks, Sue. Thank you all for joining us today. Q2 was a quarter of substantial progress as we continue to execute against the strategic priorities which support our ambition to build the premier platform for high quality, lower cost, outpatient imaging, serving health systems, physicians, and patients. These include driving strong same center growth with an expanding mix of advanced modali...